| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 71.4× | 23.7× | |
| Price / Book | 3.9× | 3.7× | |
| Price / Sales | 1.4× | 2.6× | |
| Price / Free cash flow | −7.1× | −8.9× | |
| EV / EBITDA | 50.7× | 16.1× | |
| Earnings yield | 1.4% | 2.2% | |
| Free cash flow yield | −14.0% | −3.4% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LENSE:LENSKARTLenskart Solutions Ltd · 🇮🇳 NSE | ₹631.95 | −1.25% | $11.55B | 225.2× | 5.6% | — |
RUNSE:RUBICONRubicon Research Ltd · 🇮🇳 NSE | ₹1,430.50 | −3.78% | $2.5B | 99.9× | 19.1% | — |
MONSE:MOLBIOMolbio Diagnostics Limited · 🇮🇳 NSE | ₹1,366.10 | −4.79% | $1.66B | 114.4× | 15.0% | — |
CONSE:CORONACorona Remedies Ltd · 🇮🇳 NSE | ₹2,020.20 | +0.51% | $1.3B | 66.5× | 24.8% | — |
SYNSE:SYMBIOTECSymbiotec Pharmalab Limited · 🇮🇳 NSE | ₹1,227.40 | −0.90% | $828.06M | 82.1× |
| 11.9% |
| — |
KPNSE:KPLKwality Pharmaceuticals Ltd · 🇮🇳 NSE | ₹3,455.60 | +2.66% | $376.17M | 51.7× | 20.3% | — |
SHNSE:SHUKRAPHARShukra Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹68.36 | −0.38% | $316.39M | 136.9× | 24.5% | — |
FRNSE:FREDUNFredun Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹1,389.90 | −3.37% | $240.42M | 72.5× | 11.7% | — |
SANSE:SAIPARENTSai Parenteral's Ltd · 🇮🇳 NSE | ₹482.05 | −0.20% | $224.05M | 149.6× | 2.9% | — |
BENSE:BETABeta Drugs Ltd · 🇮🇳 NSE | ₹1,665.90 | −3.12% | $194.29M | 46.0× | 16.9% | −5.3% |
